[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. reported a Form 144 notice indicating a proposed sale of 32,455 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,966,062.45. The filing shows these shares were originally acquired on 02/15/2019 in a Series Seed preferred-stock transaction from the issuer and payment was recorded on the same date. The seller represents there have been no undisclosed material adverse facts about the issuer. The filing lists the approximate date of sale as 08/27/2025 and identifies NASDAQ as the exchange. No securities were reported sold by the filer in the past three months.

Insights

Securities Analyst

TL;DR: Routine insider sale notice of 32,455 common shares (~$3.0M); size is immaterial versus outstanding shares.

The Form 144 documents a proposed sale by a person who acquired the shares in a Series Seed preferred-stock conversion on 02/15/2019. At an stated outstanding share count of 370,470,348, the proposed 32,455-share sale represents roughly 0.009% of shares outstanding, indicating minimal dilution or market-impact risk. The broker is Morgan Stanley Smith Barney LLC and the planned execution date is 08/27/2025 on NASDAQ. No sales were reported in the past three months. This is a standard compliance filing under Rule 144 and appears procedural rather than a signal of material corporate change.

Corporate Governance Expert

TL;DR: Compliance disclosure consistent with Rule 144 requirements; seller affirms no undisclosed material information.

The notice includes the seller's representation that they lack any undisclosed material adverse information about the issuer, and it documents origin of the shares as a Series Seed preferred-stock acquisition from the issuer. Signature and attestation language is present as required. The absence of recent sales and the small proportion of outstanding shares suggest ordinary insider liquidity rather than governance concern. Documentation appears complete for a Form 144 based on the provided fields.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32455	2966062.45	370470348	08/27/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2019	Series Seed preferred stock	Issuer			32455	02/15/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CoreWeave's (CRWV) Form 144 report show?

The filing reports a proposed sale of 32,455 common shares worth $2,966,062.45, to be executed on or about 08/27/2025 via Morgan Stanley Smith Barney LLC on NASDAQ.

When were the shares being sold originally acquired for the Form 144 filing?

The shares were acquired on 02/15/2019 through a Series Seed preferred stock transaction from the issuer, with the same date listed for payment.

How large is the proposed sale relative to CoreWeave's outstanding shares?

The filing lists 370,470,348 shares outstanding; the proposed 32,455 shares are approximately 0.009% of outstanding shares, a negligible proportion.

Did the filer report any sales in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.

Who is the broker handling the proposed sale in the Form 144?

The broker is listed as Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza 8th Floor, New York, NY 10004.